Skip to main content
. 2016 Oct 18;13(11):825–834. doi: 10.7150/ijms.16185

Table 2.

The association between individual benzodiazepine use and dementia based on the FAERS database.

Cases Non-cases ROR 95% CI IC 95% CI
Benzodiazepines 50,302 1,001,070 1.63 1.61-1.64 0.66 0.65-0.67
Short-acting 800 18,637 1.38 1.28-1.48 0.44 0.34-0.55
Etizolam 691 16,019 1.38 1.28-1.49 0.45 0.34-0.56
Clotiazepam 107 2,597 1.32 1.09-1.60 0.38 0.10-0.67
Flutazolam 2 21 3.05 0.72-13.01 0.80 -0.97-2.56
Medium-acting 35,772 739,016 1.56 1.54-1.58 0.61 0.59-0.62
Lorazepam 16,245 327959 1.59 1.57-1.62 0.64 0.62-0.66
Alprazolam 18,075 384,519 1.51 1.49-1.53 0.57 0.55-0.59
Fludiazepam 3 279 0.34 0.11-1.07 -1.26 -2.71-0.20
Bromazepam 1,444 26,161 1.77 1.68-1.87 0.79 0.71-0.87
Nimetazepam 5 98 1.63 0.67-4.02 0.53 -0.68-1.74
Long-acting 13,186 233,750 1.81 1.78-1.85 0.82 0.79-0.84
Diazepam 11,267 195,417 1.85 1.82-1.89 0.85 0.82-0.88
Cloxazolam 200 3,084 2.08 1.80-2.40 1.00 0.79-1.21
Chlordiazepoxide 740 17,880 1.33 1.23-1.43 0.39 0.28-0.50
Medazepam 15 220 2.18 1.29-3.69 0.97 0.23-1.72
Clorazepate 964 17,149 1.80 1.69-1.92 0.81 0.72-0.91
Ultra-long-acting 544 9,667 1.80 1.65-1.97 0.81 0.69-0.94
Flutoprazepam 6 161 1.19 0.53-2.70 0.20 -0.91-1.32
Loflazepate 185 3,483 1.70 1.47-1.97 0.73 0.51-0.95
Mexazolam 7 182 1.23 0.58-2.62 0.24 -0.80-1.29
Oxazolam 18 294 1.96 1.22-3.16 0.86 0.18-1.54

Cases: number of reports of dementia

Non-cases: all reports of adverse drug reactions other than dementia

ROR: reporting odds ratio

IC: information component

CI: confidence interval

HHS Vulnerability Disclosure